Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?

Cancer Sci. 2015 Aug;106(8):1100. doi: 10.1111/cas.12708.

Authors

Yasutsuna Sasaki^{1

2}, Kazuyuki Hamada¹, Toshikado Kaneta¹, Takehiro Takahashi¹, Yutaro Kubota¹, Hiroo Ishida¹, Wataru Ichikawa¹

Affiliations

¹ Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
² Institute of Molecular Oncology, Showa University, Tokyo, Japan.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Humans
Male
Pancreatic Neoplasms / drug therapy*